E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.

P Cartwright; H Müller; C Wagener; K Holm; K Helin

doi:10.1038/sj.onc.1201975

E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.

P Cartwright, H Müller, C Wagener, K Holm, K Helin

159 Citations (Scopus)

Abstract

The E2F family of transcription factors are essential for the regulation of genes required for appropriate progression through the cell cycle. Five members of the E2F family have been previously reported, namely E2F1-5. All five are key elements in transcriptional regulation of essential genes, and they can be divided into two functional groups, those that induce S-phase progression when overexpressed in quiescent cells (E2Fs 1-3), and those that do not (E2Fs 4-5). Here, we describe the identification of a novel member of this family, which we refer to as E2F-6. E2F-6 shares significant homology with E2Fs 1-5, especially within the DNA binding, heterodimerization and marked box domains. Unlike E2Fs 1-5, E2F-6 lacks a transactivation and a pocket protein binding domain, hence, forms a unique third group within the E2F family. E2F-6 is a nuclear protein that can form heterodimers with the DP proteins (both DP-I and DP-2) in vitro and in vivo. Our results show that the complex formed between E2F-6 and the DP proteins, possesses high DNA binding activity, displaying a preference for a TTTCCCGC E2F recognition site, which is slightly different to the E2F consensus site derived from the E2 promoter (TTTCGCGC). In contrast to the other members of the E2F family, ectopic expression of E2F-6 inhibits transcription from promoters possessing E2F recognition sites rather than activating transcription. In addition, overexpression of E2F-6 suppresses the transactivational effects of coexpression of E2F-1 and DP-1. The inhibitory effect of E2F-6 is dependent on its DNA binding activity and its ability to form heterodimers with the DPs. Interestingly, ectopic expression of E2F-6 leads to accumulation of cells in S-phase. Our data suggest that E2F-6 expression delays the exit from S-phase rather than inducing S-phase, which further emphasizes the functional difference between E2F-6 and the previously known E2F family members.

Original language	English
Journal	Oncogene
Volume	17
Issue number	5
Pages (from-to)	611-23
Number of pages	12
ISSN	0950-9232
DOIs	https://doi.org/10.1038/sj.onc.1201975
Publication status	Published - 1998

Access to Document

10.1038/sj.onc.1201975

Cite this

@article{ed50a9e053dc11dd8d9f000ea68e967b,

title = "E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.",

abstract = "The E2F family of transcription factors are essential for the regulation of genes required for appropriate progression through the cell cycle. Five members of the E2F family have been previously reported, namely E2F1-5. All five are key elements in transcriptional regulation of essential genes, and they can be divided into two functional groups, those that induce S-phase progression when overexpressed in quiescent cells (E2Fs 1-3), and those that do not (E2Fs 4-5). Here, we describe the identification of a novel member of this family, which we refer to as E2F-6. E2F-6 shares significant homology with E2Fs 1-5, especially within the DNA binding, heterodimerization and marked box domains. Unlike E2Fs 1-5, E2F-6 lacks a transactivation and a pocket protein binding domain, hence, forms a unique third group within the E2F family. E2F-6 is a nuclear protein that can form heterodimers with the DP proteins (both DP-I and DP-2) in vitro and in vivo. Our results show that the complex formed between E2F-6 and the DP proteins, possesses high DNA binding activity, displaying a preference for a TTTCCCGC E2F recognition site, which is slightly different to the E2F consensus site derived from the E2 promoter (TTTCGCGC). In contrast to the other members of the E2F family, ectopic expression of E2F-6 inhibits transcription from promoters possessing E2F recognition sites rather than activating transcription. In addition, overexpression of E2F-6 suppresses the transactivational effects of coexpression of E2F-1 and DP-1. The inhibitory effect of E2F-6 is dependent on its DNA binding activity and its ability to form heterodimers with the DPs. Interestingly, ectopic expression of E2F-6 leads to accumulation of cells in S-phase. Our data suggest that E2F-6 expression delays the exit from S-phase rather than inducing S-phase, which further emphasizes the functional difference between E2F-6 and the previously known E2F family members.",

author = "P Cartwright and H M{\"u}ller and C Wagener and K Holm and K Helin",

note = "Keywords: Amino Acid Sequence; Animals; Base Sequence; Cell Cycle; Cell Cycle Proteins; DNA, Complementary; DNA-Binding Proteins; E2F6 Transcription Factor; Gene Expression; HL-60 Cells; Humans; Molecular Sequence Data; Nuclear Proteins; Rabbits; Repressor Proteins; Sequence Homology, Amino Acid; Tissue Distribution; Transcription Factor DP1; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured",

year = "1998",

doi = "10.1038/sj.onc.1201975",

language = "English",

volume = "17",

pages = "611--23",

journal = "Oncogene",

issn = "0950-9232",

publisher = "nature publishing group",

number = "5",

}

TY - JOUR

T1 - E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.

AU - Cartwright, P

AU - Müller, H

AU - Wagener, C

AU - Holm, K

AU - Helin, K

N1 - Keywords: Amino Acid Sequence; Animals; Base Sequence; Cell Cycle; Cell Cycle Proteins; DNA, Complementary; DNA-Binding Proteins; E2F6 Transcription Factor; Gene Expression; HL-60 Cells; Humans; Molecular Sequence Data; Nuclear Proteins; Rabbits; Repressor Proteins; Sequence Homology, Amino Acid; Tissue Distribution; Transcription Factor DP1; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured

PY - 1998

Y1 - 1998

N2 - The E2F family of transcription factors are essential for the regulation of genes required for appropriate progression through the cell cycle. Five members of the E2F family have been previously reported, namely E2F1-5. All five are key elements in transcriptional regulation of essential genes, and they can be divided into two functional groups, those that induce S-phase progression when overexpressed in quiescent cells (E2Fs 1-3), and those that do not (E2Fs 4-5). Here, we describe the identification of a novel member of this family, which we refer to as E2F-6. E2F-6 shares significant homology with E2Fs 1-5, especially within the DNA binding, heterodimerization and marked box domains. Unlike E2Fs 1-5, E2F-6 lacks a transactivation and a pocket protein binding domain, hence, forms a unique third group within the E2F family. E2F-6 is a nuclear protein that can form heterodimers with the DP proteins (both DP-I and DP-2) in vitro and in vivo. Our results show that the complex formed between E2F-6 and the DP proteins, possesses high DNA binding activity, displaying a preference for a TTTCCCGC E2F recognition site, which is slightly different to the E2F consensus site derived from the E2 promoter (TTTCGCGC). In contrast to the other members of the E2F family, ectopic expression of E2F-6 inhibits transcription from promoters possessing E2F recognition sites rather than activating transcription. In addition, overexpression of E2F-6 suppresses the transactivational effects of coexpression of E2F-1 and DP-1. The inhibitory effect of E2F-6 is dependent on its DNA binding activity and its ability to form heterodimers with the DPs. Interestingly, ectopic expression of E2F-6 leads to accumulation of cells in S-phase. Our data suggest that E2F-6 expression delays the exit from S-phase rather than inducing S-phase, which further emphasizes the functional difference between E2F-6 and the previously known E2F family members.

AB - The E2F family of transcription factors are essential for the regulation of genes required for appropriate progression through the cell cycle. Five members of the E2F family have been previously reported, namely E2F1-5. All five are key elements in transcriptional regulation of essential genes, and they can be divided into two functional groups, those that induce S-phase progression when overexpressed in quiescent cells (E2Fs 1-3), and those that do not (E2Fs 4-5). Here, we describe the identification of a novel member of this family, which we refer to as E2F-6. E2F-6 shares significant homology with E2Fs 1-5, especially within the DNA binding, heterodimerization and marked box domains. Unlike E2Fs 1-5, E2F-6 lacks a transactivation and a pocket protein binding domain, hence, forms a unique third group within the E2F family. E2F-6 is a nuclear protein that can form heterodimers with the DP proteins (both DP-I and DP-2) in vitro and in vivo. Our results show that the complex formed between E2F-6 and the DP proteins, possesses high DNA binding activity, displaying a preference for a TTTCCCGC E2F recognition site, which is slightly different to the E2F consensus site derived from the E2 promoter (TTTCGCGC). In contrast to the other members of the E2F family, ectopic expression of E2F-6 inhibits transcription from promoters possessing E2F recognition sites rather than activating transcription. In addition, overexpression of E2F-6 suppresses the transactivational effects of coexpression of E2F-1 and DP-1. The inhibitory effect of E2F-6 is dependent on its DNA binding activity and its ability to form heterodimers with the DPs. Interestingly, ectopic expression of E2F-6 leads to accumulation of cells in S-phase. Our data suggest that E2F-6 expression delays the exit from S-phase rather than inducing S-phase, which further emphasizes the functional difference between E2F-6 and the previously known E2F family members.

U2 - 10.1038/sj.onc.1201975

DO - 10.1038/sj.onc.1201975

M3 - Journal article

C2 - 9704927

SN - 0950-9232

VL - 17

SP - 611

EP - 623

JO - Oncogene

JF - Oncogene

IS - 5

ER -

E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.

Abstract

Access to Document

Fingerprint

Cite this